Extensive resistance to chemotherapy-induced apoptosis is a complicating factor in treating pancreatic cancer and has been linked to cellular overexpression of Bcl-2 and other apoptosis inhibitors [34]. This evidence concerns the gene BCL2 and familial pancreatic carcinoma.